D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$454M |
| 2 |
Apple
AAPL
|
+$364M |
| 3 |
Procter & Gamble
PG
|
+$314M |
| 4 |
Verizon
VZ
|
+$308M |
| 5 |
Pfizer
PFE
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$735M |
| 2 |
Emerson Electric
EMR
|
+$423M |
| 3 |
Biogen
BIIB
|
+$354M |
| 4 |
PayPal
PYPL
|
+$349M |
| 5 |
Amazon
AMZN
|
+$338M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.77% |
| 2 | Healthcare | 11.58% |
| 3 | Consumer Discretionary | 8.97% |
| 4 | Financials | 7.64% |
| 5 | Communication Services | 5.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Sensata Technologies
ST
$6.65B
| $9.97M | 0.02% |
344,625
+180,094
| +109% | +$7.78M |
|
952
Akebia Therapeutics
AKBA
$327M
| $9.95M | 0.02% |
1,311,965
+524,334
| +67% | +$4.08M |
|
953
CALL
W.W. Grainger
GWW
$65.3B
| $9.94M | 0.02% |
40,000
-66,600
| -62% | -$19.7M |
|
|
LGF.B
954
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $9.91M | 0.02% |
1,776,252
-350,531
| -16% | -$2.93M |
|
|
APLS
955
DELISTED
Apellis Pharmaceuticals
APLS
| $9.9M | 0.02% |
369,733
+221,326
| +149% | +$7.86M |
|
956
CALL
McCormick & Company Non-Voting
MKC
$13.4B
| $9.9M | 0.02% |
140,200
+78,200
| +126% | +$6.07M |
|
957
Haemonetics
HAE
$3.58B
| $9.89M | 0.02% |
99,285
-3,089
| -3% | -$335K |
|
|
VAR
958
DELISTED
Varian Medical Systems, Inc.
VAR
| $9.87M | 0.02% |
96,160
-161,598
| -63% | -$21.3M |
|
959
Littelfuse
LFUS
$10.2B
| $9.82M | 0.02% |
73,621
+27,136
| +58% | +$4.54M |
|
960
PUT
General Dynamics
GD
$105B
| $9.79M | 0.02% |
74,000
-31,600
| -30% | -$5.25M |
|
|
NBIS
961
Nebius Group N.V.
NBIS
$47.7B
| $9.74M | 0.02% |
286,078
+84,544
| +42% | +$3.49M |
|
|
TWNK
962
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
| $9.69M | 0.02% |
909,062
-909,264
| -50% | -$11.5M |
|
|
KSU
963
DELISTED
Kansas City Southern
KSU
| $9.68M | 0.02% |
76,125
+7,261
| +11% | +$1.11M |
|
964
Selective Insurance
SIGI
$5.74B
| $9.68M | 0.02% |
194,707
+19,197
| +11% | +$1.17M |
|
965
A.O. Smith
AOS
$8.38B
| $9.65M | 0.02% |
255,175
-51,006
| -17% | -$2.17M |
|
966
Insulet
PODD
$11.3B
| $9.64M | 0.02% |
58,161
-89,452
| -61% | -$16.3M |
|
967
PUT
Sherwin-Williams
SHW
$78.3B
| $9.6M | 0.02% |
62,700
-14,100
| -18% | -$2.54M |
|
|
BMY.RT
968
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $9.59M | 0.02% |
2,524,432
-50,356
| -2% | -$166K |
|
969
PUT
American International
AIG
$41.9B
| $9.56M | 0.01% |
394,200
+129,600
| +49% | +$5.56M |
|
970
ScottsMiracle-Gro
SMG
$4.03B
| $9.56M | 0.01% |
93,353
+82,812
| +786% | +$9.11M |
|
971
Central Garden & Pet Co Class A
CENTA
$2.41B
| $9.55M | 0.01% |
466,821
-147,155
| -24% | -$3.27M |
|
972
Abercrombie & Fitch
ANF
$4.17B
| $9.53M | 0.01% |
1,048,560
-722,165
| -41% | -$10.5M |
|
973
CALL
DuPont de Nemours
DD
$18.6B
| $9.53M | 0.01% |
222,668
+30,297
| +16% | +$1.85M |
|
|
SYNH
974
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $9.52M | 0.01% |
241,581
-9,162
| -4% | -$536K |
|
975
Alcoa
AA
$11.7B
| $9.51M | 0.01% |
1,544,273
-962,207
| -38% | -$13.2M |
|
Similar funds
D.E. Shaw & Co's Q1 2020 Portfolio in Review
As of Q1 2020, D.E. Shaw & Co held 4,498 positions worth $64.1B, down 27% from $87.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co withdrew a net $5.59B in Q1 2020, closing 626 positions and reducing 1,723 holdings. Its most notable exit was PG&E, an estimated $79M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, D.E. Shaw & Co opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $124M.
- D.E. Shaw & Co's largest Q1 2020 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,005,000 shares worth $124M.
- D.E. Shaw & Co added most to ExxonMobil in Q1 2020, an estimated $454M increase.
- D.E. Shaw & Co's biggest Q1 2020 reduction was Tesla, cutting an estimated $735M.
- D.E. Shaw & Co fully exited PG&E in Q1 2020, selling an estimated $79M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $64.1B portfolio in Q1 2020.
- D.E. Shaw & Co opened 538 new positions and closed 626 in Q1 2020.
- D.E. Shaw & Co's portfolio value fell 27% quarter-over-quarter to $64.1B.
Based on D.E. Shaw & Co's 13F filing for Q1 2020, filed 15 May 2020.